Pharma executives, scientists, and founders gathered in Boston for the annual Aging Research and Drug Discovery meeting. For the first time, the FDA also attended the conference. Longevity is now being taken seriously in the pharmaceutical industry as an investment imperative.
Related Articles
Don't miss out on breaking stories and in-depth articles.